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Background: The aim of this study was to compare maternal labour and birth outcomes between women who
gave birth on a birth seat or in any other position for vaginal birth and further, to study the relationship between
synthetic oxytocin augmentation and maternal blood loss, in a stratified sample.
Methods: A re-analysis of a randomized controlled trial in Sweden. An on-treatment analysis was used to study
obstetrical outcomes for nulliparous women who gave birth on a birth seat (birth seat group) compared to birth in
any other position for vaginal birth (control group). Data were collected between November 2006 and July 2009.
The outcome measurements included perineal outcome, post partum blood loss, epidural analgesia, synthetic
oxytocin augmentation and duration of labour.
Results: The major findings of this paper were that women giving birth on the birth seat had shorter duration of
labour and were significantly less likely to receive synthetic oxytocin for augmentation in the second stage of
labour. Significantly more women had an increased blood loss when giving birth on the birth seat, but had no
difference in perineal outcomes. Blood loss was increased regardless of birth position if women had been exposed
to synthetic oxytocin augmentation during the first stage of labour.
Conclusions: The results of this analysis imply that women with a straightforward birth process may well benefit
from giving birth on a birth seat without risk for any adverse obstetrical outcomes. However it is important to bear
in mind that, women who received synthetic oxytocin during the first stage of labour may have an increased risk
for greater blood loss when giving birth on a birth seat. Finally it is of vital importance to scrutinize the influence of
synthetic oxytocin administered during the first stage of labour on blood loss postpartum, since excessive blood
loss is a well-documented cause of maternal mortality worldwide and may cause severe maternal morbidity in
high-income countries.
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Interventions in the childbirth process can, in both
high- and low-income countries, save the lives of
mothers and infants and in some cases reduce the oc-
currence of serious sequelae [1,2]. However, the general
premise of current obstetric practice is that pregnancy
and childbirth are medical processes; justifying intense
risk management [3,4]. Medical–technical interventions
are introduced into the birth process in what often
becomes a “cascade of interventions”. Examples of such
interventions are epidural analgesia, synthetic oxytocin
for augmentation of labour, continuous electronic fetal
monitoring and horizontal position in the second stage
of birth [5,6]. It is well known that the majority of
women in high-income countries, as well as in some
low-income countries give birth in a horizontal position,
despite repeated evidence for the numerous beneficial
outcomes of upright birth positions [7-9].
It is more than 20 years since Waldenström and
Gottvall [10] published results from a randomised con-
trolled trial (RCT) of birth on a birth seat in a Swedish
study that comprised 294 birthing women (compliance
rate 49.3%). They reported from their study, which was
analysed according to intention-to-treat (ITT), that par-
ticipants in the experimental group had a significantly
larger blood loss, a higher rate of maternal satisfaction
and midwives attending birth seat births were less con-
tent with their working posture. A similar compliance
rate (49.5%) was shown in a more recent Swedish RCT
which reported obstetric outcomes in 1020 nulliparous
women who were randomized to birth on a birth seat
(experimental group) or to birth in any other position
(control group) [9]. Analysis was by ITT. The main find-
ing of the RCT was that there was no significant reduc-
tion in instrumental vaginal births in women allocated
to the experimental group. Additionally, there was a sig-
nificant increase in the experimental group for blood
loss between 500 ml and 999 ml but no increase in
bleeding above 1000 ml and no increase in perineal
lacerations or perineal oedema [9]. A secondary analysis,
also carried out according to the ITT principal, was per-
formed to assess whether birth on the birth seat affected
the use of synthetic oxytocin for augmentation of the
second stage of labour, duration of labour and infant
outcomes. The main findings of that analysis were that
women allocated to the birth seat had a significantly
shorter second stage of labour despite similar numbers
of women who received synthetic oxytocin augmentation
in both groups and that neonatal outcomes did not differ
between the groups [11].
The randomized controlled trial is considered to be
the most reliable method for empirical research and has
in recent decades played an important role in producing
evidence for midwifery and obstetric practice [12-14].Johnson emphasizes, in “Childbirth and Authoritative
Knowledge” edited by Davis-Floyd and Sarget [15], that
the RCT is an important ally for supporting and further
developing low-intervention, woman-centred midwifery
care. According to some authors the most appropriate
and recognized way to analyse results collected in an
RCT is to perform an analysis according to the ITT
principal [13,16]. When randomization is carried out
meticulously the ITT analysis maintains the advantages
of baseline comparability of the groups as well as balan-
cing known and unknown confounders [17,18]. Never-
theless, analysis by the ITT principle in a sample with
considerable non-compliance cannot demonstrate how
an intervention affects the individual who complies with
the allocation, since assessment will be diluted by the
data from participants who do not receive the interven-
tion to which they were randomly allocated [18]. Ana-
lysis according to the received treatment or “on-
treatment” (OT) analysis is carried out without regard to
the initial randomization and may be considered as a
complement to ITT analysis when non-compliance
is substantial, however with an increased risk for
selection bias [18]. There was considerable non-
compliance (49.5%) to randomization in the RCT by
Thies-Lagergren et al. [9,11] and it is important to at-
tempt to understand if the results, which showed a shor-
tened second stage of labour and increased blood loss
were associated with the use of the birth seat per se.
Therefore, the present article is in response to collea-
gues’, researchers’ and reviewers’ questions about how
the results of the maternal outcomes in the two ITT
analyses [9,11] might be, if analysis was carried out
according to how women actually gave birth (OT).
The aim of this re-analysis was to compare maternal
labour and birth outcomes between women who gave
birth on a birth seat or in any other position for vaginal
birth and further, to study the relationship between syn-
thetic oxytocin augmentation and maternal blood loss,
in a stratified sample.
Methods
The present article is based on data collected in an RCT
by Thies-Lagergren et al. [9,11] and is a re-analysis of
the following outcomes; synthetic oxytocin for augmen-
tation of labour, perineal outcomes (episiotomies/lacera-
tions/oedema), postpartum blood loss, duration of
labour. An additional analysis regarding use of epidural
analgesia was carried out.
Design and trial size
This is an OT analysis of an RCT that was originally
powered to detect differences in instrumental vaginal
births, based on an arbitrary reduction of instrumental
births from 15% to 9% (α = 0.05, ß = 0.2). Of the 1002
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emergency caesarean section, leaving 950 for analysis
according to the OT principal. Analyses include 253 nul-
liparous women, referred to as the birth seat group, who
gave birth on the birth seat compared to 697 nulliparous
women, here referred to as the control group, who gave
vaginal birth in any other position.
Inclusion criteria
The participants spoke Swedish sufficiently well to re-
ceive information and give informed consent or refusal
for participation in the trial. Inclusion criterion were a
healthy woman with an uncomplicated pregnancy exclu-
sive of any medical diagnosis, a singleton foetus in ceph-
alic presentation, a Body Mass Index (BMI) less than 30
and a spontaneous onset of labour occurring between
gestational weeks 37 + 0 and 41 + 6. Women diagnosed
with gestational diabetes not requiring medical treat-
ment were included. Also included were women with a
history of caesarean section who now planned a vaginal
birth (VBAC) and women induced because of spontan-
eous rupture of membranes without spontaneous con-
tractions for longer than twenty-four hours.
Recruitment of study participants
Midwives working in antenatal clinics invited women to
join the study and provided oral and written informa-
tion. Eligible women who accepted participation gave
written consent and this was documented in the
women’s case notes. The women were at liberty to with-
draw their consent throughout the whole trial. The
included women gave birth at two hospitals in Sweden,
which were chosen for convenience. The assisting mid-
wife, who checked that the inclusion criteria were met,
confirmed eligibility for participation in the trial on ad-
mission to the delivery ward.
Data collection
Data collection sheets contained the woman’s date of
birth, personal identification number and randomization
number. In case of non-compliance to randomization,
the midwives were asked to record any reason for this
on the data collection sheet. All other outcome measure-
ments were available from the electronic case notes.
Outcome measurements
The principal outcome measurements were post-
partum blood loss and perineal outcome (episiotomies/
lacerations/oedema).
Secondary outcomes were epidural analgesia, synthetic
oxytocin for augmentation of first and second stage of
labour and overall duration of labour. Infant outcomes
are not reported in this paper since results of theprevious analyses showed that very few infants (3.0 %)
were transferred to the NICU.
Statistical analyses
The data were analyzed using PASW (Predictive Analy-
tics Software) version 20.0. Due to diversion from the
original randomisation, a statistical comparison between
the groups for demographic variables was carried out.
We calculated odds ratios (OR) with a 95% confidence
interval, for epidural analgesia, augmentation of labour,
duration of labour, blood loss and perineal outcome be-
tween women who gave birth on the birth seat versus
those who did not. Step-wise logistic regression analysis
was used to examine the net effects of birth position
and synthetic oxytocin for augmentation on blood loss
greater than 500 ml. In the analysis the odds ratios
were adjusted for maternal age, BMI, smoking, cervix
status at admission, for epidural analgesia, fetal head
circumference, fetal weight, gestational age, oxytocin
augmentation and duration of first and second stage of
labour.
Ethical considerations
All participants included in the analysis were given
standard midwifery care during birth. There is no evi-
dence suggesting that giving birth on a birth seat should
involve increased pain or medical risks for the birthing
mother or her infant. There is an increased risk for
blood loss between 500–999 ml, however, this has been
shown to be without clinical relevance for participants
[11]. The study has been approved by the committee for
research ethics at Lund University [Dnr 214/2005 and
Dnr 2009/739].
Results
The group of 253 women in this analysis who gave
birth on the birth seat comprises 246 (49.2%) of the
500 who were originally allocated to the experimental
group and 7 (0.1%) from the control group who gave
birth on the birth seat. All women who did not give
birth on the birth seat, irrespective of allocation, are
included in the control group. None in the birth seat
group had an instrumental vaginal birth.
Table 1 shows demographic variables for the partici-
pants. There were significantly fewer women in the birth
seat group who reported smoking.
Table 2 shows comparisons of labour outcomes be-
tween birth seat births and all other vaginal births. Sta-
tistically significantly differences were shown between
the two groups; the birth seat group had shorter first
(p = <0.01) and second (p = <0.01) stages of labour than
the control group. These findings remain significant
after adjustments. There was no difference between the
groups for duration of the third stage of labour.
Table 1 Demographic variables birth seat births compared to all other positions excl. ceaserean section
Birth seat group Control group RR/mean difference
n= 253 n= 697 (95% CI) P-value
n (%) n (%)
Age groups
< 25 years 44 (17.4) 121 (17.3) 1.00 (0.73 - 1.37) 1.00
25-35 years 192 (75.1) 495 (71.1) 1.06 (0.98 - 1.16) 0.14
> 35 years 19 (7.5) 81 (11.6) 0.64 (0.40 - 1.04) 0.07
Body Mass Index (SD) 22.7 (±5.1) 22.7 (±5.1) 0.37 (0.80 - 6.65) 0.85
Smoking 22 (8.0) 95 (13.6) 0.63 (0.41 - 0.99) 0.04
Previous caesarean section 2 (0.7) 7 (1.0) 0.78 (0.16 - 3.76) 1.00
Gestational Age
< 37 + 6 weeks 10 (3.9) 29 (4.1) 0.95 (0.47 - 1.91) 1.00
38 + 0 - 40 + 6 weeks 202 (79.8) 521 (74.7) 1.06 (0.99 - 1.15) 0.12
> 41 + 0 weeks 41 (16.2) 147 (21.0) 0.76 (0.56 - 1.08) 0.09
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tation initiated during the first and second stages of
labour showed that less women in the birth seat group
were given synthetic oxytocin for labour augmentation
during both the first stage (p = <0.01) and the second
stage (p = 0.05) of labour. However after adjustment
only augmentation in the second stage of labour
remained statistically significant.
Epidural analgesia was administered to 37% of the
women in the birth seat group compared to 45% in the
control group, which represented a statistically signifi-
cant difference, but when adjusted for potential con-
founders the difference disappeared.
Statistically significantly more women who gave birth
on the birth seat had a measured blood loss of 500 ml or
more. The odds for increased blood loss were higher
even after adjustment.
Among the total number of participating women,
14.7 % had a documented blood loss more than 1000 ml.
In order to more fully understand the relationship be-
tween blood loss and augmentation, a stratified analysis
was performed between the birth seat group and the
control group and results are shown in Table 3. This
analysis showed that there was no difference for blood
loss from 500 to 999 ml between those with or without
augmentation during the first stage of labour, in the
birth seat group. However, those in the birth seat group
who received synthetic oxytocin significantly more often
bled over 1000 ml (p = 0.04).
In the control group there were significantly more
women who had a blood loss between 500 – 999 ml
(p = 0.04) and significantly more who had a blood
loss over 1000 ml (p = 0.003) when they had received
synthetic oxytocin during first stage of labour.
Perineal outcomes are also shown in Table 2. Among
the women who gave birth on the birth seat five (2%)had an episiotomy performed compared to 90 (13.7%) in
the control group, which was statistically significant (p =
<0.01). There were no statistically significant differences
for any degree of perineal lacerations. Oedema was mea-
sured on a visual analogue scale (VAS) between 24–36
hours after birth and no difference was demonstrated
between the groups.Discussion
The major findings in this paper were that women giving
birth on the birth seat had shorter duration of labour
and were significantly less likely to receive synthetic oxy-
tocin for augmentation in the second stage of labour.
There were no differences in perineal outcomes between
the groups. Significantly more women had an increased
blood loss when giving birth on the birth seat. Blood loss
was increased regardless of birth position if women had
been exposed to synthetic oxytocin augmentation during
the first stage of labour.
These findings altogether reveal the complexity of
interventions used in contemporary obstetric practice;
one might ask: what came first, the chicken or the egg?
It may be speculated that women who gave birth on the
birth seat had a more straightforward labour, were less
tired and experienced less pain, making them less
exposed to interventions. It is known that upright birth
positions improve contractions, make pain easier to han-
dle and enhance shorter duration of labour, and should
therefore be used as an intervention to facilitate a
straightforward birth [19-23]. Experiences of physio-
logical birth may enhance midwives trust in the birth
process and lessen the tendency for intervention. On the
other hand, women whose labours are not straightfor-
ward may request a more medical approach from the
midwife, wishing for the introduction of interventions to
Table 2 Labour outcomes of birth seat births compared to all other positions (ceacarean section excluded)
Birth seat group Control group Crude Adjusted
n= 253 n= 697 Odds Ratio P-value Odds Ratio P-value
n (%) n (%) (95% CI) (95% CI)
Duration of labour
First stage of labour in minutes* 397 (± 191) 465 (± 240) 0.99 (0.99 - 0.99) <0.01 0.99 (0.99 - 1.00) <0.01
Second stage of labour in minutes** 32 (± 18) 44 (± 27) 0.97 (0.70 - 0.98) <0.01 0.97 (0.96 - 0.98) <0.01
Third stage of labour in minutes*** 14 (± 17) 13 (± 14) 1.00 (0.99 - 1.03) 0.34 1.00 (0.99 - 1.01) 0.22
Augmentation of labour
No augmentation 127 (50.2) 202(28.9) 1.0 Ref. 1.0 Ref.
Augmentation initiated during
first stage of labour****
90 (35.6) 355 (50.9) 0.40 (0.29 - 0.56) <0.01 0.74 (0.49 - 1.13) 0.17
Augmentation initiated during
second stage of labour*****
36 (14.2) 140 (20.1) 0.66 (0.44 - 0.98) 0.04 0.49 (0.29 - 0.86) <0.01
Epidural analgesia****** 94 (37.0) 314 (45.0) 0.72 (0.54 - 0.97) 0.03 1.14 (0.75 - 1.73) 0.54
Blood loss*******
< 499 ml 86 (34.0) 355 (51.1) 1.0 Ref. 1.0 Ref.
500-999 ml 128 (50.6) 246 (35.1) 1.43 (1.22 - 1.68) <0.01 2.20 (1.48 - 3.26) <0.01
>1000 ml 39 (15.4) 96 (13.8) 1.67 (1.08 - 2.60) 0.02 2. 00 (1.19 - 3.37) <0.01
Mean blood loss in ml. (SD)******* 709 (± 462) 592 (± 448) 117 <0.01 1.00 (1.00 - 1.01) <0.01
Episiotomies******* 5 (2.0) 90 (13.7 ) 0.15 (0.06 - 0.37) <0.01 0.19 (0.07 - 0.54) <0.01
Perineal lacerations*******
No laceration 10 (4.0) 40 (6.1) 1.0 Ref. 1.0 Ref.
1 degree 184 (73.8) 458 (69.8) 1.06 (0.97 - 1.15) 0.25 1.63 (0.70 - 3.80) 0.26
2.degree 42 (16.8) 118 (17.9) 1.93 (0.68 - 1.30) 0.77 1.53 (0.60 - 3.89) 0.37
3.degree 13 (5.2) 40 (6.1) 0.85 (0.47 - 1.57) 0.75 1.76 (0.60 - 5.29) 0.31
Oedema*******
1 (vas 0-3) 184 (85.2) 419 (83.4) 1.0 Ref. 1.0 Ref.
2 (vas 4-7) 30 (13.8) 70 (13.9) 0.99 (0.67 - 1.48) 1.00 1.79 (0.35 - 8.77) 0.51
3 (vas 8-10) 2 (0.9) 13 (2.6) 0.35 (0.08 - 1.57) 0.25 2.54 (0.48 - 13.64) 0.28
* Adjusted for maternal age, BMI, smoking, cx status at admission, epidural, fetal head circumference, fetal weight, gestational age.
** Adjusted for maternal age, BMI, smoking, cx status at admission, epidural, fetal head circumference, fetal weight, gestational age, duration of first stage of labour and augmentation during first stage.
***Adjusted for maternal age, BMI, smoking, cx status at admission, epidural, fetal head circumference, fetal weight, gestational age, duration of first and second stages, augmentation during first and second stages.
**** Adjusted for maternal age, BMI, smoking, cx status at admission, epidural, fetal head circumference, fetal weight, gestational age and duration of first stage of labour.
*****Adjusted for maternal age, BMI, smoking, cx status at admission, epidural, fetal head circumference, fetal weight, gestational age, oxytocin augmentation in first stage of labour and duration of first and second
stages of labour.
******Adjusted for maternal age, BMI, smoking, cx status at admission, fetal head circumference, fetal weight, gestational age, oxytocin augmentation in/and duration of first and second stages of labour.



















Table 3 Stratified analysis of blood loss in relation to augmentation with synthetic oxytocin
Birth seat group Control group
No oxytocin initiated Oxytocin initiated OR (95% CI) No oxytocin initiated Oxytocin initiated OR (95% CI)
during first stage during first stage for oxytocin during during first stage during first stage for oxytocin during
Blood loss n (%) n (%) first stage n (%) n (%) first stage
<499 ml 63 (38cif.6) 23 (25.5) 1.0 Ref. 193 (56.4) 162 (45.5) 1.0 Ref.
500-999 ml 79 (48.6) 49 (54.5) 1.7 (0.9-3.1) 113 (33.0) 133 (37.0) 1.4 (1.0 -1.9)**
>1000 ml 21 (12.8) 18 (20.0) 2.3 (1.1-5.1)* 36 (10.6) 60 (17.5) 2.0 (1.2-3.1)**
No oxytocin initiated Oxytocin given OR (95% CI) No oxytocin given Oxytocin given OR (95% CI)
during second stage during second stage for oxytocin during during second stage during second stage for oxytocin during
Blood loss n (%) n (%) second stage n (%) n (%) second stage
<499 ml 51 (40.0) 12 (33.4) 1.0 Ref. 120 (59.0) 73 (52.1) 1.0 Ref.
500-999 59 (46.5) 20 (55.6) 1.5 (0.6-3.2) 62 (31.0) 51 (36.4) 1.4 (0.8-2.2)
>1000 17 (13.5) 4 (11.0) 1.0 (0.3-3.5) 20 (10.0) 16 (11.5) 1.3 (0.6-2.7)
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with childbirth.
According to the ITT analysis the second stage of
labour was significantly shorter for women who gave
birth on the birth seat and when the OT analysis was ap-
plied, it was disclosed that the overall duration of labour
for those women was shorter and duration of the second
stage of labour was even shorter (ITT = 6 min vs. OT =
12 min).
Analysis by ITT found no statistically significant differ-
ence between the groups for blood loss above 1000 ml
but according to the OT analysis, significantly more
women who gave birth on the birth seat had a blood loss
of ≥1000 ml. In accordance with earlier research, the
present analysis suggests that upright position facilitated
by the birth seat may cause a greater blood loss, however
the increased blood loss was of little clinical relevance
for the women, as reported earlier [8-10]. The greater
blood loss may be due to venous obstruction or be
caused by increased hydrostatic pressure both on the ar-
terial and venous side, which could contribute to more
bleeding from the uterus and placental site [10,24]. An-
other possible explanation for blood loss above 500 ml
may be found in the use of synthetic oxytocin for aug-
mentation. According to the ITT analysis no differences
were found between the groups regarding synthetic oxy-
tocin for labour augmentation during either the first or
second stage of labour. However, according to the OT
analysis statistically significantly less women in the birth
seat group received augmentation during second stage
of labour. The stratified analysis showed a statistically
significant association between blood loss and augmen-
tation of labour with synthetic oxytocin during the first
stage of labour regardless of group affiliation. Prolonged
labour often results in augmentation of labour and an
increased risk for post partum blood loss [25], which
may even be the case in this study. However, a
population-based study stated that synthetic oxytocin
during labour appears to be an independent risk factor
for increased blood loss, regardless of labour duration
[26]. Synthetic oxytocin is a commonly used drug in
contemporary obstetrics; it is of vital importance to fur-
ther investigate the influence of its administration during
the first stage of labour on postpartum blood loss.
Regarding perineal lacerations and perineal oedema
this analysis is consistent with the ITT analysis. There
were no increased incidences in first, second or third de-
gree perineal lacerations for women giving birth on a
birth seat, which is in contrast to earlier findings from a
systematic Cochrane-review [9,22]. Moreover, it was
shown in the present analysis that significantly fewer
women who gave birth on the birth seat had an episiot-
omy performed. This is an important finding that may
be linked to less interventions and the reduced length ofthe second stage of labour in these women. Gupta et al.,
[22] reported likewise that upright position in the sec-
ond stage of labour for women without epidural anal-
gesia resulted in a considerable reduction in episiotomy.
In hospitals, trust in medical guidelines rather than
the physiological process of birth is common [27]. Some
researchers have discussed how midwives attitudes to
labour and birth might have an impact on labour pro-
gress [28]. The present analysis has not investigated
midwives attitudes, nevertheless is it important to note
that our analysis removes non-compliers, which might
mean that the women who gave birth on the birth seat
were attended by a midwife who was generally more
positive to the idea of upright birthing positions.
Methodological considerations
It is a great challenge to conduct and achieve high com-
pliance in RCTs carried out in an intrapartum care set-
ting [29]. The primary reason for the present analysis
was the substantial non-compliance, which occurred in
the RCT, making the ITT approach challenging. It has
been suggested that full ITT analysis is only meaningful
when complete outcome data are available for all sub-
jects included in an RCT [16,18]. In our case, data were
complete but the substantial non-compliance prompted
us to consider an alternative analysis. An OT analysis
answers questions about true effect by analysing the
received intervention rather than the allocated interven-
tion [18]. However, it has also been suggested that al-
though OT analysis may provide clinically relevant
information and valuable clarifications in the assessment
of interventions, ITT remains the most reliable way to
interpret analyses of RCTs [19]. The present OT analysis
of the data originating from the RCT has inherent
limitations because of the loss of the benefits of
randomization and a risk for selection bias. However,
this issue was in part addressed by carrying out a
statistical comparison of demographic data between
the groups.
It is important to bear in mind that the women who
participated in the trial probably had a positive attitude
towards the birth seat when they initially agreed to join
the study. The results from the OT analysis might also
have pin-pointed those women who were motivated to
give birth without interventions and who wanted to and
actually gave birth on the birth seat. Further research to
understand the negotiation process between the midwife
and the birthing woman will be of great interest.
Our results indicate that it may be relevant to combine
the two methods of analysis when compliance is
reduced. In a letter to the editor of the journal “Infection
Control and Hospital Epidemiology”, Herigon & New-
land [30] suggested that both a strict ITT and an OT
analysis should be used to inform the overall conclusions
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estimates of the true effect, which likely lies somewhere
between the two estimates, while offering different
trade-offs.
Conclusion
We have illustrated that non-compliance in intra-
partum studies remains a problem and that choice of
method of analysis has a considerable impact on results
obtained. This fact leads us to reflect on cause and ef-
fect: the chicken or the egg? Results of this analysis
imply that women with a straightforward birth process
may well benefit from giving birth on a birth seat with-
out risk for any adverse obstetrical outcomes. However
it is important to bear in mind that women who receive
synthetic oxytocin during the first stage of labour, may
have an increased risk for blood loss ≥ 1000 ml, regard-
less of birth position. Finally it is of vital importance to
scrutinize the influence of synthetic oxytocin adminis-
tered during the first stage of labour on blood loss post-
partum, since excessive blood loss is a well-documented
cause of maternal mortality worldwide and may cause
maternal morbidity even in high-income countries.
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